HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11
August 04, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition
July 19, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., July 19, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility
July 18, 2022 08:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., July 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery
July 06, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., July 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer
June 29, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., June 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG to Sponsor Keynote Presentation Featuring Customer Use of its HTG EdgeSeq Technology in Clinical Trials
June 08, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., June 08, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022
June 06, 2022 16:27 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., June 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
REVISION - HTG to Host Scientific Webinar Featuring Customer Use of the HTG Transcriptome Panel in Preclinical and Clinical Programs
June 01, 2022 17:40 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., June 01, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG to Host Scientific Webinar Featuring Customer Use of the HTG Transcriptome Panel in Preclinical and Clinical Programs
June 01, 2022 16:20 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., June 01, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference
May 17, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., May 17, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...